Dr. Seth Whitelaw has more than 25 years of industry experience in the life sciences and healthcare sectors, as an attorney, compliance officer, and consultant. His career has focused on food and drug law and corporate governance, as well as designing and running compliance programs within medical devices, pharmaceutical sales, and marketing and pharmaceutical R&D. He is a licensed food and drug attorney, with a doctorate in Health Law. A former Food and Drug Law Institute (FDLI) fellow, he also worked for the FDA’s Office of Chief Counsel and Deloitte & Touche LLP.
Dr. Whitelaw has served as a compliance officer for several pharmaceutical and medical device companies including as the Chief Compliance Officer (C.R., Bard, Inc. and Misonix, Inc.), head of pharmaceutical commercial compliance (SmithKline Beecham Pharmaceuticals North America), and global compliance officer for R&D (GlaxoSmithKline). In each case, he has designed, built and implemented a compliance program from a “blank sheet of paper.”
In addition, he teaches at the Mitchell Hamline School of Law and edits for the Life Science Compliance Update, a monthly publication providing comprehensive, up-to-date compliance information for pharmaceutical, biotechnology, and medical device manufacturers.